Revenue Growth
Full year 2024 revenue grew by 5% compared to 2023, with fourth quarter revenue increasing 6% sequentially and 5% year-over-year.
Gross Margin Improvement
Gross margin improved to 62% in Q4 2024, driven by lower production costs, representing a significant improvement from 52% in 2023.
Adjusted EBITDA Increase
Adjusted EBITDA increased by $98 million to $420 million for full year 2024, a 30% increase from 2023, with a 37% margin in Q4 2024.
Customer Retention and Loyalty Program Success
Customer retention improved to 68% overall and 76% in medical-only markets, with loyalty program members spending 2.3 times more than non-members.
Successful Expansion and Retail Optimization
Trulieve added 33 new stores in 2024, ending the year with 225 locations, and plans to open 10 more in 2025 while refreshing or remodeling up to 45 dispensaries.